Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Translational oncology [Transl Oncol] NLMUID: 101472619"" wg kryterium: JN


Tytuł :
Bioengineered microfluidic blood-brain barrier models in oncology research.
Autorzy :
Augustine R; Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, 2713 Doha, Qatar; Biomedical Research Center (BRC), Qatar University, PO Box 2713 Doha, Qatar. Electronic address: .
Aqel AH; Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, 2713 Doha, Qatar; Biomedical Research Center (BRC), Qatar University, PO Box 2713 Doha, Qatar.
Kalva SN; Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, 2713 Doha, Qatar; Biomedical Research Center (BRC), Qatar University, PO Box 2713 Doha, Qatar.
Joshy KS; Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, 2713 Doha, Qatar; Biomedical Research Center (BRC), Qatar University, PO Box 2713 Doha, Qatar.
Nayeem A; Department of Biotechnology, St. Mary's College, Thrissur 680020, Kerala, India.
Hasan A; Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, 2713 Doha, Qatar; Biomedical Research Center (BRC), Qatar University, PO Box 2713 Doha, Qatar. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr 14; Vol. 14 (7), pp. 101087. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Radiomic profiling of clear cell renal cell carcinoma reveals subtypes with distinct prognoses and molecular pathways.
Autorzy :
Lin P; Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China.
Lin YQ; Department of Radiology, The Affiliated Dongnan Hospital of Xiamen University, Zhangzhou, Fujian Province 363020, China.
Gao RZ; Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China.
Wen R; Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China.
Qin H; Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China.
He Y; Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China.
Yang H; Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr 13; Vol. 14 (7), pp. 101078. Date of Electronic Publication: 2021 Apr 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Novel antigens of CAR T cell therapy: New roads; old destination.
Autorzy :
Safarzadeh Kozani P; Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Safarzadeh Kozani P; Department of Medical Biotechnology, Faculty of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran; Student Research Committee, Medical Biotechnology Research Center, School of Nursing, Midwifery, and Paramedicine, Guilan University of Medical Sciences, Rasht, Iran.
Rahbarizadeh F; Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran; Research and Development Center of Biotechnology, Tarbiat Modares University, Tehran, Iran. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr 13; Vol. 14 (7), pp. 101079. Date of Electronic Publication: 2021 Apr 13.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Thrombotic microangiopathy in oncology - a review.
Autorzy :
Valério P; Nephrology Department, Setúbal Hospital Center, Portugal Rua Camilo Castelo Branco 175, 2910-549 Setúbal, Portugal. Electronic address: .
Barreto JP; Laboratory Diagnosis Department, Portuguese Oncology Institute of Porto, Portugal Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Ferreira H; Nephrology Department, Portuguese Oncology Institute of Porto, Portugal Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Chuva T; Nephrology Department, Portuguese Oncology Institute of Porto, Portugal Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Paiva A; Nephrology Department, Portuguese Oncology Institute of Porto, Portugal Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Costa JM; Nephrology Department, Portuguese Oncology Institute of Porto, Portugal Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr 12; Vol. 14 (7), pp. 101081. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Loss of tumor suppressive properties of lipid metabolism enzyme CPT2 in ovarian carcinoma: Comment on "CPT2 down-regulation promotes tumor growth and metastasis through inducing ROS/NFκB pathway in ovarian cancer" by Zhang et al.
Autorzy :
Vlachostergios PJ; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, 520 East 70th street, New York, NY 10021, USA. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr 12; Vol. 14 (7), pp. 101067. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
ROS mediated apoptotic pathways in primary effusion lymphoma: Comment on induction of apoptosis by Shikonin through ROS-mediated intrinsic and extrinsic pathways in primary effusion lymphoma.
Autorzy :
Dwivedi P; Department of Microchemistry, Proteomics, and Lipidomics, Genentech Inc. 1 DNA Way, South San Francisco, CA 94080, United States. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr 12; Vol. 14 (7), pp. 101061. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A recombinant Chinese measles virus vaccine strain rMV-Hu191 inhibits human colorectal cancer growth through inducing autophagy and apoptosis regulating by PI3K/AKT pathway.
Autorzy :
Zhang CD; Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, Zhejiang. China; Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang. China. Electronic address: .
Wang YL; Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, Zhejiang. China. Electronic address: .
Zhou DM; Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, Zhejiang. China. Electronic address: .
Zhu MY; Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, Zhejiang. China; Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang. China. Electronic address: .
Lv Y; Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, Zhejiang. China. Electronic address: .
Hao XQ; Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, Zhejiang. China. Electronic address: .
Qu CF; Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, Zhejiang. China; Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang. China. Electronic address: .
Chen Y; Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, Zhejiang. China; Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang. China. Electronic address: .
Gu WZ; Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, Zhejiang. China. Electronic address: .
Wu BQ; University of Chinese Academy of Sciences Shenzhen Hospital, Shenzhen 518000, China. Electronic address: .
Chen PC; University of Chinese Academy of Sciences Shenzhen Hospital, Shenzhen 518000, China. Electronic address: .
Zhao ZY; Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, Zhejiang. China; Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang. China. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr 10; Vol. 14 (7), pp. 101091. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Comparative analysis of triple-negative breast cancer transcriptomics of Kenyan, African American and Caucasian Women.
Autorzy :
Saleh M; Department of Medicine, University of Alabama at Birmingham, Birmingham 35233, AL, United States; Department of Hematology-Oncology, the Aga Khan University, Nairobi, Kenya; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham 35233, AL, United States.
Chandrashekar DS; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Shahin S; Department of Pathology, the Aga Khan University, Nairobi, Kenya.
Agarwal S; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Kim HG; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Behring M; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Shaikh AJ; Department of Pathology, the Aga Khan University, Nairobi, Kenya.
Moloo Z; Department of Pathology, the Aga Khan University, Nairobi, Kenya.
Eltoum IA; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Yates C; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States; Department of Biology & Center for Cancer Research, Tuskegee University, Tuskegee, AL, United States.
Varambally S; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham 35233, AL, United States; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Manne U; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham 35233, AL, United States; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr 08; Vol. 14 (7), pp. 101086. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes.
Autorzy :
Cheng HC; School of Medicine, College of Medicine, Kaohsiung Medical University, Taiwan.
Chang TK; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, No. 100 Tzyou 1st Road, Kaohsiung City 807, Kaohsiung, Taiwan.
Su WC; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, No. 100 Tzyou 1st Road, Kaohsiung City 807, Kaohsiung, Taiwan.
Tsai HL; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, No. 100 Tzyou 1st Road, Kaohsiung City 807, Kaohsiung, Taiwan; Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Wang JY; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, No. 100 Tzyou 1st Road, Kaohsiung City 807, Kaohsiung, Taiwan; Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Taiwan; Graduate Institute of Medicine, Kaohsiung Medical University, Taiwan; Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Center for Liquid Biopsy and Cohort Research, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr 07; Vol. 14 (7), pp. 101089. Date of Electronic Publication: 2021 Apr 07.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy.
Autorzy :
Mortoglou M; Cancer Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, UK. Electronic address: .
Tabin ZK; Cancer Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, UK. Electronic address: .
Arisan ED; Institution of Biotechnology, Gebze Technical University, Gebze, Turkey. Electronic address: .
Kocher HM; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University London, London EC1M 6BQ, UK. Electronic address: .
Uysal-Onganer P; Cancer Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, UK. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr 05; Vol. 14 (7), pp. 101090. Date of Electronic Publication: 2021 Apr 05.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma.
Autorzy :
Liu X; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China.
Zhang Y; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China.
Li K; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China.
Liu Y; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China.
Xu J; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China.
Ma J; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China.
An L; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China.
Wang H; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China.
Chu X; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr 01; Vol. 14 (7), pp. 101085. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Neuron specific enolase promotes tumor metastasis by activating the Wnt/β-catenin pathway in small cell lung cancer.
Autorzy :
Zha Z; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China.
Li D; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China.
Zhang P; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China.
Wang P; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China.
Fang X; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China.
Liu X; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China.
Weng C; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China.
Li B; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China.
Wu Y; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China.
Mao H; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China.
Wang L; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China.
Xu L; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China.
Dong J; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China.
Guan M; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China.
Lu L; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China. Electronic address: .
Liu G; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, Guangdong, China. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr; Vol. 14 (4), pp. 101039. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma.
Autorzy :
Fan C; Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin 2nd Road, Shanghai 200025, People's Republic of China.
Hu H; Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin 2nd Road, Shanghai 200025, People's Republic of China.
Shen Y; Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin 2nd Road, Shanghai 200025, People's Republic of China.
Wang Q; Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin 2nd Road, Shanghai 200025, People's Republic of China.
Mao Y; Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin 2nd Road, Shanghai 200025, People's Republic of China.
Ye B; Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin 2nd Road, Shanghai 200025, People's Republic of China. Electronic address: .
Xiang M; Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin 2nd Road, Shanghai 200025, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr; Vol. 14 (4), pp. 101042. Date of Electronic Publication: 2021 Feb 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
High preoperative albumin-bilirubin score predicts poor survival in patients with newly diagnosed high-grade gliomas.
Autorzy :
Zhang J; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. Electronic address: .
Xu Q; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. Electronic address: .
Zhang H; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. Electronic address: .
Zhang Y; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. Electronic address: .
Yang Y; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. Electronic address: .
Luo H; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. Electronic address: .
Lin X; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. Electronic address: .
He X; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. Electronic address: .
Mou Y; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. Electronic address: .
Zhou Z; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. Electronic address: .
He Z; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr; Vol. 14 (4), pp. 101038. Date of Electronic Publication: 2021 Feb 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
LncRNA HOTAIR recruits SNAIL to inhibit the transcription of HNF4α and promote the viability, migration, invasion and EMT of colorectal cancer.
Autorzy :
Jin L; Department of Oncology, Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
Pan YL; Department of Oncology, Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
Zhang J; Department of Oncology, Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
Cao PG; Department of Oncology, Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, China. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr; Vol. 14 (4), pp. 101036. Date of Electronic Publication: 2021 Feb 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
C-reactive protein-to-albumin ratio is an independent poor prognostic factor in newly diagnosed chronic lymphocytic leukaemia: A clinical analysis of 322 cases.
Autorzy :
Tang HN; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Pan BH; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Wang L; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Zhu HY; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Fan L; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Xu W; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China. Electronic address: .
Li JY; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr; Vol. 14 (4), pp. 101035. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The role of von Willebrand factor in breast cancer metastasis.
Autorzy :
Goh CY; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Dublin 4, Ireland; UCD School of Medicine, College of Health and Agricultural Sciences (CHAS), University College Dublin, Belfield, Dublin, Dublin 4, Ireland. Electronic address: .
Patmore S; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Dublin 2, Ireland.
Smolenski A; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Dublin 4, Ireland; UCD School of Medicine, College of Health and Agricultural Sciences (CHAS), University College Dublin, Belfield, Dublin, Dublin 4, Ireland.
Howard J; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Dublin 4, Ireland.
Evans S; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Dublin 4, Ireland; UCD School of Medicine, College of Health and Agricultural Sciences (CHAS), University College Dublin, Belfield, Dublin, Dublin 4, Ireland.
O'Sullivan J; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Dublin 2, Ireland.
McCann A; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Dublin 4, Ireland; UCD School of Medicine, College of Health and Agricultural Sciences (CHAS), University College Dublin, Belfield, Dublin, Dublin 4, Ireland.
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr; Vol. 14 (4), pp. 101033. Date of Electronic Publication: 2021 Feb 08.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Machine-learning analysis of contrast-enhanced computed tomography radiomics predicts patients with hepatocellular carcinoma who are unsuitable for initial transarterial chemoembolization monotherapy: A multicenter study.
Autorzy :
Jin Z; Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, China.
Chen L; Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, China.
Zhong B; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhou H; Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China.
Zhu H; Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, China.
Zhou H; Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, China.
Song J; Department of Interventional Radiology, Zhejiang University Lishui Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Central Hospital, Lishui, China.
Guo J; Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, China.
Zhu X; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Ji J; Department of Interventional Radiology, Zhejiang University Lishui Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Central Hospital, Lishui, China. Electronic address: .
Ni C; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China. Electronic address: .
Teng G; Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, China. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr; Vol. 14 (4), pp. 101034. Date of Electronic Publication: 2021 Feb 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Improved survival in several cancers with use of H 1 -antihistamines desloratadine and loratadine.
Autorzy :
Fritz I; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. Electronic address: .
Wagner P; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
Olsson H; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden; Department of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden.
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr; Vol. 14 (4), pp. 101029. Date of Electronic Publication: 2021 Feb 05.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Platelet transfusion for cancer secondary thrombocytopenia: Platelet and cancer cell interaction.
Autorzy :
Wang J; Class 2016 Clinical Medicine, Southwest Medical University, Luzhou 646000, Sichuan, China.
Zhou P; Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China.
Han Y; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China. Electronic address: .
Zhang H; Department of Blood Transfusion, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China. Electronic address: .
Pokaż więcej
Źródło :
Translational oncology [Transl Oncol] 2021 Apr; Vol. 14 (4), pp. 101022. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies